NanoVibronix is a medical device company that focuses on noninvasive biological response-activating devices that target biofilm prevention, wound healing and pain therapy and can be administered at home, without the assistance of medical personnel. Co.'s primary products, which are in various stages of clinical and market development, consist of: UroShield, which is an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use; and PainShield, which is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures. The NAOV stock yearly return is shown above.
The yearly return on the NAOV stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2020 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the NAOV annual return calculation with any dividends reinvested as applicable (on ex-dates).
|